Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical

Nazar Mashtalir1, Salima Daou1, Haithem Barbour1

  • 1Maisonneuve-Rosemont Hospital Research Center, Department of Medicine, University of Montréal, Montréal, QC H1T 2M4, Canada.

Molecular Cell
|April 8, 2014
PubMed

Insights

The ubiquitin-conjugating enzyme UBE2O targets the tumor suppressor BAP1 for cytoplasmic sequestration, a process critical for cell proliferation and tumor suppression. Disrupting this balance through cancer mutations impairs BAP1 function.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The tumor suppressor BAP1 (BRCA1-associated protein 1) plays a role in cell proliferation, but its regulatory mechanisms are not fully understood.
  • Understanding how BAP1's function is controlled is crucial for cancer research and developing targeted therapies.

Purpose of the Study:

  • To elucidate the mechanism by which the ubiquitin-conjugating enzyme UBE2O regulates BAP1.
  • To investigate the role of BAP1 autodeubiquitination in tumor suppression and its disruption in cancer.
  • To explore the broader implications of UBE2O in regulating chromatin-associated proteins and nuclear trafficking.

Main Methods:

  • Investigated the interaction between UBE2O and BAP1 using biochemical assays.
  • Analyzed the effect of UBE2O-mediated ubiquitination on BAP1 localization.
  • Studied cancer-derived BAP1 mutations to assess their impact on autodeubiquitination and localization.
  • Examined the role of UBE2O and BAP1 in adipogenesis.
  • Identified UBE2O target sequences and validated ubiquitination of chromatin remodeling factors.

Main Results:

  • UBE2O multi-monoubiquitinates BAP1's nuclear localization signal, causing cytoplasmic sequestration.
  • BAP1 autodeubiquitination, through intramolecular interactions, counteracts UBE2O's effect.
  • Cancer-associated BAP1 mutations impair autodeubiquitination, leading to cytoplasmic retention and loss of tumor suppression.
  • UBE2O promotes adipogenesis and BAP1 cytoplasmic localization.
  • UBE2O targets chromatin remodeling factors for ubiquitination, revealing a novel signaling pathway.

Conclusions:

  • UBE2O regulates BAP1 nuclear trafficking via atypical ubiquitination, impacting cell proliferation and tumor suppression.
  • BAP1 autodeubiquitination is essential for its tumor suppressor function, and its disruption in cancer contributes to disease progression.
  • This study uncovers a novel ubiquitin-signaling pathway governing chromatin-associated protein function and nuclear transport.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K